Viewing Study NCT02483260


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2026-03-06 @ 10:57 AM
Study NCT ID: NCT02483260
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2025-06-27
First Post: 2015-06-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever
Sponsor: U.S. Army Medical Research and Development Command
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module